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Available online 21 September 2016The recent Zika virus (ZIKV) epidemic has highlighted the poor knowledge on its physiopathology. Recent studies
showed that ZIKV of the Asian lineage, responsible for this international outbreak, causes neuropathology in vitro
and in vivo. However, two African lineages exist and the virus is currently found circulating in Africa. The original
African strain was also suggested to be neurovirulent but its laboratory usage has been criticized due to its mul-
tiple passages. In this study, we compared the French Polynesian (Asian) ZIKV strain to an African strain isolated
in Central African Republic and show a difference in infectivity and cellular response between both strains in
human neural stem cells and astrocytes. Consistently, this African strain led to a higher infection rate and viral
production, aswell as stronger cell death and anti-viral response. Our results highlight the need to better charac-
terize the physiopathology and predict neurological impairment associated with African ZIKV.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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The current (2015–2016) Zika virus (ZIKV) epidemic in South
America and in the Caribbean islands revealed the lack of knowledge
on the pathophysiological mechanisms of a virus discovered almost
70 years ago in Uganda (Dick et al., 1952). This arbovirus is transmitted
by vectors from the Aedes family, in particular Aedes aegypti and Aedes
albopictus. Phylogenetic analyses revealed recently that three lineages
(one Asian and two Africans) exist and explain the evolution of ZIKV
over the last 70 years (Shen et al., 2016; Gong et al., 2016). The current
epidemic is due to ZIKV from the Asian lineage, even though some
further genetic evolution seems to have occurred (Wang et al., 2016).
While a large proportion of infected persons are asymptomatic (70–
80%), others develop rather classical clinical signs of an arboviral
infection namely, skin rash, headache, myalgia, joint pain, conjunctivitis,ité deMontpellier, Etablissement
ions, Inserm,Montpellier, France.
. Simonin),
. This is an open access article underbut alsomoderate fever. In some cases, neurological disorders have been
linked to ZIKV infections, in particular Guillain-Barré syndrome (GBS),
myelitis, encephalitis, neuralgia and microcephaly in newborns and in-
fants born to women with ZIKV infection during pregnancy (Musso et
al., 2016). Microcephaly is now well documented as a direct disorder
triggered by ZIKV infection, as the virus can cross the placenta (Miner
et al., 2016), is found in the amniotic ﬂuid (Calvet et al., 2016) and can
be detected in post-mortem newborn brains (Brasil Martines et al.,
2016). In particular, infection during the ﬁrst trimester of pregnancy
has been proposed to lead to microcephaly in 1% of cases (Cauchemez
et al., 2016). Studies on animal models (rodent) show that ZIKV can
cause a similar pathology as in humans, such as trans-placental fetal
transmission and neurological impairment in fetal and adult brain
(Rossi et al., 2016; Dowall et al., 2016; Aliota et al., 2016; Cugola et al.,
2016; Lazear et al., 2016; Miner et al., 2016). However, most of these
models are based on an immunodeﬁcient background. Recent reports
clearly demonstrate that ZIKV can infect human andmurine neural pre-
cursors. Ex vivo works using induced pluripotent cells (IPSc)-derived
neural precursors cells (NPCs) and neural stem cells (NSCs) show that
ZIKV has a preferential tropism for cells of the neuronal lineage duringthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Notably, some reports suggest that impairment of proliferation and
cell death is associated with ZIKV infection (Tang et al., 2016; Li et al.,
2016), whereas another report suggests that ZIKV poorly stimulates im-
mune response and cytopathic effect in human neuroprecursors obtain-
ed from fetal tissue (Hanners et al., 2016). This lack of strong immune
responsewould allow ZIKV to persist during development and is consis-
tentwith the replication seen over fewweeks in this tissue. These obser-
vations are strengthening the hypothesis that infection early during
brain development can have drastic effects.
While most of the focus has been directed to Asian ZIKV strains or to
African MR-766, much less effort has been undertaken to monitor po-
tential circulating ZIKV of the African lineage (Grard et al., 2014;
Baraka and Kweka, 2016; Meda et al., 2016). In this context, there is
an urgent need to have clear understanding of the pathophysiological
mechanisms involved in infection by African ZIKV, in particular in
terms of neurovirulence. In other words, to know whether the neuro-
logical effects observedwith theAsian lineage are speciﬁcally associated
with the Asian strain, in terms of severity and speciﬁcity, or if we can ex-
pect African strains to lead to similar disorders. So far, most of the stud-
ies that investigated African ZIKV strain used the original strain of ZIKV
(MR-766, isolated in 1947). Lately, criticisms emerged concerning the
pertinence of this strain, isolated from primates and extensively ampli-
ﬁed in suckling mouse brains and ex vivo on cells (Haddow et al., 2012;
Musso et al., 2016).
Here, we used IPSc-derived human NSCs to better compare the neu-
ral infectivity of an Asian strain (ZIKV AS) and an African strain (ZIKV
AF) that underwent low passages. We demonstrate that this ZIKV AF
strain is more infectious than the French Polynesian ZIKV AS PF-13
strain (H/PF/2013): indeed, this strain showed a higher rate of infection,
viral production and cellular response (cell death and anti-viral re-
sponse) than ZIKV AS. Finally, we show that ZIKV AF and AS strains
also display difference in infection of human astrocytes.
2. Material and Methods
2.1. Material
Antibodies used in this study are: anti-pan-ﬂavivirus (MAB10216,
clone D1-4G2) and anti-nestin, (Millipore), anti-GFAP (Abcam),
anti-PDI and anti-activated caspase 3 (Cell Signalling Technology),
anti-TRA1-60 (Becton Dickinson) and anti-PAX6 (BioLegend). Carboxy-
ﬂuorescein succinimidyl ester (CFSE) dye was purchased from
Thermoscientiﬁc.
2.2. ZIKV Strains, Production and Cellular Infection
H/PF/2013 ZIKV of Asian lineage (French Polynesia, 2013) and
ArB41644 ZIKV of African lineage (Bangui, Central African Republic,
1989, isolated from mosquitoes by Pasteur Institute of Dakkar) were
produced andprovided by theNational Reference Center for arboviruses
(NRC) andhave both noN5 passages onVero cells. Viral stockswere pre-
pared by infecting sub conﬂuent Vero cells at themultiplicity of infection
(MOI) of 0.01 in D-MEM medium (Thermoscientiﬁc) supplemented by
2% heat-inactivated fetal bovine serum (Sigma). Cell supernatant was
collected 6 days later and viral stock harvested after centrifugation at
300g to remove cellular debris. Viral titers were determined by the
50% tissue culture infective dose (TCID50), which was calculated using
the Spearman-Kärber method (Kärber, 1931) and were expressed as
TCID50 per mL. Titers were calculated twice, once at the NRC and once
in our laboratory. Another stock from each ZIKV strain was also pro-
duced in C6/36 cells and had similar results (data not shown).
IPSc-derived NSCs and human astrocytes (see below) at 60–70%
conﬂuence were rinsed once with phosphate-buffered saline (PBS),
and ZIKV diluted to the required MOI (0.01, 0.1 or 1) was added to the
cells in a low medium volume. Cells were incubated for 2 h at 37 °Cwith permanent gentle agitation and then the inoculum was removed
and cells washed with PBS. Culture medium was added to each well,
and cells were incubated at 37 °C and 5% CO2. As control, cells were in-
cubated with the culture supernatant from Vero cells (mock condition).
2.3. NSC Generation and Maintenance
NSCs were obtained from the SAFE-IPSc platform at IRMB. Brieﬂy,
iPSCs generated from healthy patient using Lentivirus-derived vectors
were individualized with Gentle Cell Dissociation Reagent (Stemcell,
07174). They were rinsed out with Dulbecco's modiﬁed Eagle's
medium/Ham's F12 (DMEM/F-12, Gibco, 31330038) and centrifuged at
300g for 5 min. Dissociated cells were plated on matrigel at a density of
20,000–40,000 cells/cm2 and cultured in neural induction medium
(Stemcell, 05835) supplemented with 10 μM ROCK-inhibitor (Y-27632).
Cells were allowed to reach 80–90% conﬂuence over 6 days. Medium
was changed daily with neural induction medium without Y-27632.
iPSC-derived NSCs were passaged by incubation with Trypsin at 0.005%
to allow dissociation, and then seeded on poly-D-ornithine/laminin coat-
edplates at 20,000 cells/cm2 in 50%DMEM/F-12 and 50%Neurobasalme-
dium (Thermoscientiﬁc) supplemented with 1× N2 (Thermoscientiﬁc),
1× B27 (Thermoscientiﬁc), Glutamax (Thermoscientiﬁc) and β-FGF
plus EGF (Peprotech, 20 ng/mL each). The medium was changed every
two days. Cells were used between passages 5 and 8.
2.4. Astrocyte Cultures
Astrocytes were purchased from ScienCell™ and cultured according
to the manufacturer's instruction. Cells were cultured on Poly-lysine
coated plates and were used between passages 3 and 7.
2.5. Immunoﬂuorescence Assays
NSCs plated on poly-D-ornithine/laminin coverslips and astrocytes
plated on poly-D-lysin coverslips were imaged using Zeiss SP8 confocal
microscope, with 40× or 63× 1.4 NA Plan Apochromat oil-immersion
objectives. For indirect immunoﬂuorescence, cells were ﬁxed with 4%
PFA and permeabilized with 0.1% Triton X-100/PBS for 5 min at room
temperature (RT), followed by a blocking step with 2% bovine serum al-
bumin (BSA) and 10% horse serum for 30 min to 1 h at RT. Primary and
secondary antibodies were diluted in blocking solution and incubated
sequentially for 1 h at RT. Samples were thenmounted with ﬂuorescent
mountingmedium (Prolongold, Thermoﬁscher) with DAPI (Sigma) and
imaged by confocal microscopy using the Zeiss SP8 confocal micro-
scope, with 40× or 63× 1.4 NA Plan Apochromat oil-immersion objec-
tives. Nuclei and ZIKV infected cells were counted using a plugin of
the Image J software.
2.6. Flow Cytometry and CFSE Assays
NSCs were incubated with CFSE according to the manufacturer
(Thermoscientiﬁc) for 3 min at RT after enzymatic dissociation and
replated after the dye was quenched and cells were washed with PBS.
NSCs infected with ZIKV strains were collected in PBS at various days,
washed with PBS, ﬁxed with 2% PFA and analyzed with FACSCalibur
(BD Biosciences). Data analysis was performed using the FlowJo soft-
ware. Decrease in ﬂuorescence intensity is consistent with cell division.
2.7. RT-qPCR
RT-PCR on ZIKV-infected NSC supernatants was performed after
mRNA extraction with the Altona Diagnostics kit RealStar® Zika Virus
RT-PCR Kit 1.0, according to the manufacturer's instructions. Experi-
ments donewith similarMOI for ZIKV AF and AS showed equal ampliﬁ-
cation for both strains (data not shown). For PCR arrays, NSCs infected
with ZIKV AF or AS or mock-treated cells were harvested in RLT buffer
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Complementary DNAwas synthesized using Omniscript® reverse tran-
scriptase (Life Technologies). RT2 Proﬁler PCR arrays for Human Antivi-
ral Response (96 well format, Qiagen) were used for real-time
quantitative PCR analysis, with the use of the LC480 real time PCR in-
strument (Roche) and the Light Cycler 480 SYBR Green I master Mix
(Roche). Volumes of mix, cDNA, RNAse-free water, and cycling condi-
tions were determined according to manufacturer's instructions. Data
on gene expression were normalized according to data from the HPRT
housekeeping gene. Genes with uninterpretable amplifying curves
were excluded from the analysis.
2.8. Phylogenetic Analysis
The phylogenetic analysis was performed through a consensus
ﬂavivirus RT-PCR fragment that targeted a conserved NS5 gene re-
gion as previously described by Scaramozzino et al. (2001). Brieﬂy,
The NS5 PCR product was puriﬁed with the QIAquick PCR puriﬁca-
tion kit (Qiagen) and sequenced on an ABI 310 sequencerwith a ﬂuores-
cent dye terminator kit (Applied Biosystem). Sequencing primers were:
GTGTCCCAGCCGGCGGTGTCATCAGC and AACATGATGGGRAARAG
RGARAA and the PCR cycles were with an initial ampliﬁcation of 25 cy-
cles of incubation at 94 °C, 53 °C, and 72 °C for 1 min each. The resulting
sequences (ZIKV AF and ZIKV AS) and a set of sequences from both
Asian and African ZIKV isolates (Accession numbers: KF268950,
HQ234500, KF383116, LC002520, KF383119, KF383115, KF383118,
KF383117, KF993678, HQ234499, JN860885, KF258813, EU545988,
KJ776791, KU955595)were submitted to the Frenchphylogenywebsite
(http://www.phylogeny.fr) using the “one click version” for analysis.
The nucleotide sequences are aligned using the MUSCLE software,
cured with Gblocks and subsequent phylogeny performed with the
PhyML software. One hundred bootstrap data sets with random se-
quence addition were computed to generate a consensus tree, rooted
with a West Nile isolate sequence (AY532665), through TreeDyn.
2.9. Statistical Analyses
For all quantitative analyses, a minimum of three independent ex-
periments were performed. Student's t-test or Mann-Whitney test
were performed to analyze unpaired data. A p b 0.05 is reported as
signiﬁcant.
2.10. Ethic Statement
All experiments for IPSc generation were performed with the
approval of local biomedical ethic committee.
3. Results
3.1. Two African and Asian ZIKV Strains Show Different Infectivity in
IPS-derived NSCs
There is no consistency regarding ZIKV strain usage and relevance,
which make difﬁcult any true comparison of the neurovirulence be-
tween African and Asian strains. To have a better understanding on
how ZIKV infect the central nervous system (CNS) and potential differ-
ences between lineages, we decided to use two low-passage ZIKV
strains as it is known that RNA viruses can easily derive upon culture.
These two strainswere provided by the French National Reference Cen-
ter and were isolated from the Asian lineage (PF-13, isolated in French
Polynesia in 2013, hereafter named ZIKV AS) and an African strain
(ArB41644, isolated in Central African Republic in 1989, hereafter
namedZIKVAF),whichpartial sequencing showed that it has strongho-
mology to other strains of the African lineage I (Fig. 1A) (Shen et al.,
2016). IPS-derived NSCs were obtained according to standard methods
(see Material and Methods section and Supplemental Figure 1A).Consistent with previous report, in NSCs infected with ZIKV AS at
multiplicity of infection (MOI) of 1, we detected efﬁcient ZIKV repli-
cation after 4 days by an immunoﬂuorescence (IF) assay using a pan-
ﬂavivirus antibody (Fig. 1B). This staining was in close proximity to
the endoplasmic reticulum, labeledwith anti-PDI, a common replica-
tion site for Flaviviruses (Fig. 1B). When we performed comparative
analyses of ZIKV AF and AS infection at different MOIs (1, 0.1 and
0.01), we reproducibly detected a higher infection rate for ZIKV AF
than for ZIKV AS (Fig. 1C and D). Interestingly, even with a log differ-
ence in MOI, ZIKV AF led to more infected NSCs than ZIKV AS (Fig.
1D). Notably, percentage of infected cells at stronger MOI for ZIKV
AS was not signiﬁcantly higher (data not shown). Importantly, we
used other NSCs clones and other ZIKV AF and AS stocks from C6/
36 cells (Aedes albopictus cells) and showed similar differences be-
tween the strains (data not shown). CPE (cytopathic effect) analyses
in supernatants from NSCs at day 4 post-infection showed again a
signiﬁcant difference in viral titers quantiﬁed by TCID (tissue culture
infective dose) 50 between ZIKV AF and ZIKV AS (Fig. 1E). Kinetics of
viral production showed early dichotomy in viral titers as differences
were already seen from day 1 post-infection (Fig. 1F). Finally, real-
time RT-PCR from supernatants harvested at day 4 post-infection
(MOI 1) showed also a higher relative viral charge for ZIKV AF
(Fig. 1G).
Together, these data suggest that both lineages are efﬁciently
targeting NSCs and that neurovirulence and neuropathologies are likely
to be associatedwith this ZIKVAF strain as it infects and replicatesmore
efﬁciently than ZIKV AS in NSCs.
3.2. Cellular and Anti-viral Responses in ZIKV-infected NSCs
In a recent study, minimum cell death and cell cycle impairment in
neuronal precursors upon infection with ZIKV from the Asian lineage
was reported, suggesting that the virus could establish persistence in
this cell type (Hanners et al., 2016).We therefore next sought to charac-
terize the cellular response in ZIKV AF- and ZIKV AS-infected NSCs by
undertaking comparative analyses. Few multi-nucleated cells could be
observed at day 4 post-infection with both lineages, possibly resulting
from endoreplication (Fig. 2A), which is not observed in non-infected
cells and suggests defect in the cell cycle. We therefore monitored cell
division in ZIKV-infected NSCs by ﬂow cytometry analyzes. Using the
CFSE dye, which is cell-permeable incorporated to cellular proteins
and which ﬂuorescence is serially lost upon cell division, we analyzed
cell cycle progression in non-infected, ZIKV AF- and ZIKV AS-infected
(MOI 1) NSCs. Fig. 2B shows representative graphs after 2, 4, and
6 days post-infection. No signiﬁcant differences were seen in cell cycle
progression 2 and 4 days after infection, whereas NSCs infected with
ZIKV AF showed an important impairment in cell division after 6 days
post-infection (Fig. 2B). ZIKV AS-infected cells also displayed delayed
division, albeit much less than ZIKV AF-infected NSCs (Fig. 2B). Similar
that what was reported by Hanners et al. (2016) with another Asian
strain (PRVABC59), we found low cell death associated with infection
at day 4 as seen by the presence of few fragmented nuclei and activated
caspase 3, amarker of apoptosis, for both lineages, even though ZIKV AF
infection led tomore apoptotic nuclei than ZIKV AS (Fig. 2C and D). Sur-
prisingly, in ZIKV-infected conditions, we also observed non-infected
cells positive for activated-caspase 3 that could suggest bystander cell
death, possibly related to cytokine production following infection.
Using bright light, we also scarcely detected “rounded” cells, which
suggest a poor CPE at early time post-infection (day 4) (Supplemental
Figure 1B).
To better characterize and compare the cellular response to ZIKVAF-
and AS-NSC infection, we performed a PCR array consisting of 79 genes
involved in anti-viral responses (see Material and Methods section and
Supplemental Table 1). NSCs were infectedwith ZIKV AF or ZIKV AS at a
MOI of 1 and mRNA collected at day 4 post-infection. Twenty genes
were signiﬁcantly modulated in NSCs upon ZIKV AF infection (Fig. 3A
Fig. 1.Differential infectivity of ZIKV AF and AS in human IPSc-derived NSCs. (a) Phylogenetic analysis of ZIKV strains used in this studywas performed through a consensus ﬂavivirus RT-
PCR fragment that targeted a conserved NS5 gene region. Bootstrap values are indicated at main nodes. (b) Indirect immunoﬂuorescence (IF) of ZIKVAS-infectedNSCs (MOI 1, day 4 post-
infection) where the nucleus is stained using DAPI (cyan), the endoplasmic reticulum is stained using an anti-PDI (green) and the virus is labeled using a pan-ﬂavivirus antibody
(magenta). Scale bar = 10 μm. (c) IF of non-infected (NI), ZIKV AF- and ZIKV AS-infected NSCs (MOI 1, day 4 post-infection). The virus is labeled using a pan-ﬂavivirus antibody
(magenta) and nuclei by DAPI (false colored in green). Scale bar = 10 μm. (d) Quantitative analyses show differences in rate of infection between ZIKV AF and ZIKV AS that is
consistently seen using different MOIs. 4 independent experiments were quantiﬁed with 200–600 cells per conditions. Results are expressed as means ± SEM and analyzed using an
unpaired t-test **p b 0.01. (e) Viral titers were determined by TCID50 on Vero cells. Supernatants from NSCs infected at different MOIs and collected day 4 post-infection show
differential titers between ZIKV AF and AS, even when % of infected cells were taken in account (green curve, ZIKV AS corrected, titer normalized assuming same infection rate than
ZIKV AF (i.e. 41%). Results are expressed as means ± SEM, for three independent experiments and analyzed using Mann-Whitney test *p b 0.05. (f) Kinetics of viral production show
early dichotomy in viral replication between ZIKV AF and ZIKV AS. Day 0 corresponds to the input inoculum. Results are expressed as means ± SEM, for three independent
experiments and analyzed using Mann-Whitney test *p b 0.05. (g) Quantitative RT-PCR done on extracts of supernatants from NSCs infected at MOI 1 by the different ZIKV strains and
collected at day 4 post-infection shows also a difference in the relative physical viral load between ZIKV AF and AS. CTs from amplifying curves were arbitrarily converted using
internal control (see Material and Methods section). Results of three independent experiments are expressed as means of relative charges ± SEM and analyzed using Mann-Whitney
test. *p b 0.05.
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lar pattern recognition receptor (PRR) genes DDX58 (RIG-I), IFH1
(MDA5) and TLR3, and accompanied by an increase N400 times in
IFNB1 expression, whereas no IFNA variation was found, as recentlydescribed (Hanners et al., 2016). Only one gene was found to be signif-
icantly downregulated, namely the chemokine CXCL8, an important
mediator of the inﬂammatory responses to many viruses and bacteria
(Fig. 3D). The antiviral response to ZIKV AS in NSCs was quite different
Fig. 2. Effect of ZIKVAF andAS onNSC cell cycle and survival. (a) Nuclear fragmentation or endoreplication in ZIKV-infected cells. IF of ZIKV-infectedNSCs (ZIKVAF or ASMOI 1 day 4 post-
infection). Thenucleus is labeledwithDAPI (false colored in green) and viruseswith a pan-ﬂavivirus antibody (magenta). Scale bar=5 μm. (b) Flow cytometry analyses of NSCs incubated
with CFSE at day 0 and infectedwith ZIKV AF and AS for 2 to 6 days. The shift in ﬂuorescence is consistent with cell division. (c) IF of non-infected (NI), ZIKV AF and ZIKV AS-infected NSCs
(MOI 1, day 4 post-infection) show the presence of apoptotic cells in infected cells (white arrows show condensed nuclei and anti-activated caspase 3 is in green). Scale bar= 10 μm. (d)
Apoptotic nuclei were quantiﬁed in ZIKV AF and AS-infected NSCs at day 4 post-infection. Three independent experimentswere quantiﬁedwith 200–400 nuclei per condition. Results are
expressed as means ± SEM and analyzed using an unpaired t-test *p b 0.05.
165Y. Simonin et al. / EBioMedicine 12 (2016) 161–169as no genes were signiﬁcantly upregulated (Fig. 3B). Interestingly, four
genes were down regulated: CXCL8, similar to ZIKV AF, CXCL10, CASP1
and CTSS (Fig. 3D). As mentioned previously, the percentage of in-
fected cells by the Asiatic strain at stronger MOI is not signiﬁcantly
higher, suggesting that the cytokine response remains weak in NSCs
ZIKV AS-infected cells.
This set of data suggest that these two ZIKV AF and ZIKV AS strains
differentially affect cellular responses, whether during the cell cycle or
for the anti-viral response, and could potentially lead to pathophysio-
logical differences in vivo depending of the strain involved.
3.3. Human Astrocytes Are Permissive for ZIKV Infection
The putative ZIKV attachment factor AXL is highly expressed in as-
trocytes (Nowakowski et al., 2016). Moreover, astrocyte hypertrophy
has been seen in animal models of ZIKV infection (Bell et al., 1971)and astrocytic activation is often described during Flavivirus infections
(King et al., 2007). In this context, we characterized ZIKV AF and ZIKV
AS susceptibility in this cell type. Using primary human astrocytes, we
could detect efﬁcient ZIKV infection (Fig. 4A). When we performed
quantitative comparative analyses of the infection rate, we could show
that (i) here also ZIKV AF led to a higher cellular infection rate than
ZIKV AS and (ii) ZIKV AF and AS were potentially more efﬁcient in
terms of percentage of infection in astrocytes that in NSCs (75% vs 25%
for ZIKV AF at MOI 0.1 and 43% vs 9.7% for ZIKV AS at MOI 0.1) (Fig. 4B
and C). Consistently, viral titers determined by TCID50 showed a signif-
icant difference between strains, albeit less marked than in NSCs, sug-
gesting that this feature could be found in several cell types (Fig. 4D).
However, the difference between ZIKV AF and ZIKV AS production
were less important than in NSCs.
These data open new questions regarding the cellular response in
the brain after ZIKV infection as astrocytes play crucial roles in immune
Fig. 3. Anti-viral response in NSCs infected by ZIKV AF or AS. (a) and (b) Volcano plots of genes modulated upon ZIKV infection in NSCs. mRNA from supernatants of NSCs infected with
ZIKVAF (a) or ZIKVAS (b) atMOI 1 for 4 dayswere subjected to qRT-PCRanalyses. The experimentwas performed in triplicates and eachpoint represents themean. Statistically signiﬁcant
changes in fold regulation appear in the top-right cadran (genes upregulated) and top-left cadran (genes downregulated). (c) and (d) Fold regulation of statistically signiﬁcant genes
modulated (upregulated (c) or downregulated (d)) upon ZIKV AF and AS-infection shown in (a) and (b). Results are expressed as means ± SD and analyzed using an unpaired t-test
*p b 0.05.
166 Y. Simonin et al. / EBioMedicine 12 (2016) 161–169response, synaptogenesis and blood brain barrier (BBB) integrity among
other processes.
4. Discussion
In this study, we show signiﬁcant differences in the infectivity and
cellular response between two Asian and African ZIKV strains. Using acombination of cell and molecular biology approaches, we observed in
two human neural cell types (NSCs and astrocytes) a higher infectivity
for the African strain. Similarly to the accumulating evidences reporting
infection of neural stem or precursor cells by ZIKV, we report that both
ZIKV AF and AS can infect IPSc-derived NSCs. However, ZIKV AF led to a
stronger modulation of cellular homeostasis, in term of effects on cell
cycle progression and anti-viral response. We also report that both
Fig. 4. Human astrocytes are permissive to ZIKV infection. (a) IF of ZIKV AS-infected
astrocytes (MOI 1, day 4 post-infection). The astrocytic marker GFAP is detected using a
speciﬁc antibody (green) and the virus is labeled with a pan-ﬂavivirus antibody
(magenta) and nuclei by DAPI (cyan). Scale bar = 10 μm. (b) IF of ZIKV AF and ZIKV AS-
infected astrocytes (MOI 0.1, day 4 post-infection). The virus is labeled using a pan-
ﬂavivirus antibody (magenta) and nuclei by DAPI (false colored in green). Scale bar =
20 μm. (c) Quantitative analyses show differences in rate of infection between ZIKV AF
and ZIKV AS (MOI 0.1, day 4 post-infection). Three independent experiments were
quantiﬁed with 150–200 cells per condition. Results are expressed as means ± SEM and
analyzed using an unpaired t-test **p b 0.01. (d) Viral titers from supernatant of ZIKV AF
and AS-infected astrocytes (MOI 0.1, day 4 post-infection) were determined by TCID50 on
Vero cells. Three independent experiments were quantiﬁed. Results are expressed as
means ± SEM and analyzed using an unpaired t-test *p b 0.05.
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the pathogenesis of this Flavivirus in the developing and adult brain as
this most abundant cell type in the brain is responsible for multiple
functions such as BBB maintenance, synaptogenesis and immune regu-
lation among others (Molofsky and Deneen, 2015).
The reports of the ﬁrst suspected cases of microcephaly in Brazil in
2015 (Schuler-Faccini et al., 2016; ECDC, 2015; COES, 2016) led to an
unprecedented effort of the scientiﬁc community to understand the
pathophysiological mechanisms of a virus barely characterized, despite
its discovery almost 70 years ago. Numerous studies were subsequently
published describing the placental transcytosis of ZIKV (Bayer et al.,
2016; Miner et al., 2016) and highlighting the strong tropism for
neural precursor cells (Tang et al., 2016; Qian et al., 2016; Lazear et al.,
2016; Dang et al., 2016; Cugola et al., 2016). These observations,
together with cohort studies and the demonstration of viral shedding
in the amniotic ﬂuid and in fetal tissue (brain included), provide
strong conclusions regarding the link between ZIKV infection and
microcephaly. Retrospective studies in French Polynesia also reported
neurodevelopmental disorders associated with ZIKV infection
(Besnard et al., 2016), suggesting that this feature of ZIKV was not spe-
ciﬁc to the Brazilian epidemic. Regarding Africa, due to the poor surveil-
lance and traceability in the human health system, it is difﬁcult to
apprehend and predict the circulation of this virus (Meda et al., 2016).
However, Cape Verde has reported an outbreak and several cases
were recently found in Guinea-Bissau (both due to ZIKV of the Asian lin-
eage) in 2015–2016. Occasional studies or reports show that ZIKV AFstrains are currently circulating and support the need to closelymonitor
ZIKV AF (Baraka and Kweka, 2016; Grard et al., 2014; Van Esbroeck et
al., 2016).
Surprisingly, we repeatedly detected a stronger infectivity, viral pro-
duction and cellular response of the ZIKVAF strain ArB41644 vs ZIKV AS
strainH/PF/2013 ex vivo in neural cells. Because there is strong probabil-
ity that these strains have not derived due to extensive passages (no N5
passages for both strains), our observations could suggest a potential
difference in the physiopathology between the two strains. A rather
common trait among Flaviviruses is their ability to access the CNS and
cause neuronal impairment (Neal, 2014). However, some Flaviviruses
can display strain-dependent neurovirulence. For instance, the
neuroinvasive potential of West Nile virus (WNV) is strain-dependent
but mostly because of difference in their ability to reach the CNS
(Beasley et al., 2002). However, in some case this difference could also
be due to different replication abilities in cells of the BBB or directly in
neural cells, as was shown for WNV (Hussmann et al., 2013) and the
Alphavirus Semliki Forest virus (Fazakerley et al., 2002). One mecha-
nism responsible for difference in neurovirulence is the glycosylation
status of the envelope protein (Kawano et al., 1993; Shirato et al.,
2004). Crystal structure of ZIKV demonstrated that its envelop protein
contains a glycosylation site at Asn154 (Dai et al., 2016; Kostyuchenko
et al., 2016), similarly to the site responsible for neuroinvasiveness of
WNV (Beasley et al., 2005). Moreover, passage history likely inﬂuenced
glycosylation sites in the (original) MR-766 strain (Haddow et al.,
2012). This observation, among other critics such as number and way
of passages, are suggesting that MR-766 may not be the ideal African
reference strain. In this context, a study described a stronger replication
in a Brazilian ZIKV strain in NPCs as compared to the MR-766 strain,
which therefore appears to have less capacity of replication than the
low passage African strain used in our study (Cugola et al., 2016).
Regarding the anti-viral response occurring during ZIKV infections,
few reports using different cell types led to different observations.
ZIKV AS (H/PF/2013) has been shown to induce an innate antiviral re-
sponse in primary human skin ﬁbroblasts characterized by the upregu-
lation of TLR3,DDX58 (RIG-I) and IFIH1 (MDA5)mRNAexpression, three
PRRs known to be activated by viral dsRNA (Hamel et al., 2015). This up-
regulation is associatedwith an increase of Type-1 IFN and several inter-
feron-stimulated genes (ISGs) including OAS2, ISG15, andMX1. Several
chemokines as CXCL10, or the inﬂammatory antiviral chemokine
CCL5, were also induced by ZIKV AS in this cellular context. H/PF/2013
also stimulated the production of Type-I IFNs, ISGs, and pro-inﬂamma-
tory cytokines in the human lung epithelial cell line A549 (Frumence
et al., 2016). Human choriocarcinoma JEG-3 cells can be infected both
by ZIKV AS (FSS13025 of Cambodian origin) and ZIKV AF (MR-766)
leading to release of antiviral type III IFN as well as the ISG 2′-5′-
oligoadenylate synthetase 1 (OAS1), whereas placental trophoblasts
(PHT) appear to be refractory to ZIKV infection probably due to the
fact that PHT cells constitutively release the anti-viral type III interferon
IFNλ1 (Bayer et al., 2016). In the neuronal context, and similarly towhat
wedetected for the ZIKVAF strain inNSCs, TLR3was shown to beupreg-
ulated in cerebral organoids and human neurospheres after ZIKV MR-
766 strain infection by RT-qPCR analysis (Dang et al., 2016). However,
more recently, Hanners et al. demonstrated that ZIKV AS (PRVABC59,
Puerto Rico, 2015) did not stimulate cytokine secretion in human
neuroprecursors (hNPs) and in the THP-1 human monocytic cells
(Hanners et al., 2016). Although a viral RNAmimic (pIC) can induce cy-
tokine responses in hNPs, these neural progenitors appears therefore
refractory to the inductionof neuroinﬂammatory or neuroprotective cy-
tokines in response to this ZIKV AS strain (Hanners et al., 2016). This is
consistent with our observation in NSCs where H/PF/2013, contrary to
ZIKV AF, did not lead to any upregulation of genes involved in anti-
viral response and triggered the down-regulation of CXCL8, CXCL10,
CASP1 and CTSS. Similarly to what was proposed by Hanners et al., our
data strongly suggest that ZIKV AS could persist and replicate in a pro-
portion of infected NSCs, albeit we cannot nevertheless exclude that
168 Y. Simonin et al. / EBioMedicine 12 (2016) 161–169ZIKV AS could infectmore cells at longer time and lead to a stronger cel-
lular impairment. This could however explain why ZIKV AS is found in
newborns who were infected during the ﬁrst trimester of pregnancy
(Johansson et al., 2016). It is tempting to speculate that ZIKV AS being
poorly cytopathic and immunogenic could establish cellular reser-
voir(s). This could lead to impairment of neuronal development
through subtle mechanisms such as cell cycle modiﬁcation and low
noise apoptosis.
Finally, in themature and developing brain, astrocytes are one of the
ﬁrst cell type to respond to viral infection (Furr andMarriott, 2012). As-
trocyte hypertrophy has been detected in a mouse model of ZIKV infec-
tion (Bell et al., 1971) and is occurring for other Flavivirus CNS infection
such as WNV (Hussmann et al., 2013), DENV (Lee et al., 2016) and the
Alphavirus CHIKV (Inglis et al., 2016). Interestingly, AXL, a molecule
suggested as a putative attachment receptor for ZIKV (Hamel et al.,
2015) is highly expressed in NSCs but also in astrocytes (Nowakowski
et al., 2016). Indeed, using single-cell RNA-seq approaches and
conﬁrming with immunohistochemistry, the authors showed that
NSCs, radial glial cells, astrocytes and also microglia are expressing
AXL and could therefore represent a target of choice for ZIKV
(Nowakowski et al., 2016). Moreover recent studies described permis-
siveness of astrocytes to AS strains of ZIKV and that AXL receptor de-
creased ZIKV infection in human astrocytes ex vivo (Xu et al., 2016;
Retallack et al., 2016). Recent histopathological studies in ZIKV-infected
newborns showed the presence of viral antigens in glial cells (Martines
et al., 2016). These sets of observations prompted us tomonitor the per-
missibility of astrocytes to ZIKV AS and AF infection. Surprisingly, we
found a higher infection rate in astrocytes than in NSCs for both line-
ages. One possible explanation would be a differential use of receptors
betweenNSCs and astrocytes or a difference in AXL expression between
these cell types. Interestingly, there was also a difference in infectivity
between ZIKV AF and AS, albeit less pronounced than in NSCs. In this
context, the effect of ZIKV infection on astrocyte homeostasis, in partic-
ular immune and anti-viral response will be particularly pertinent to
study. Finally, astrocytes are constantly involved in cell-to-cell contact
and could potentially favor viral spread to other cell types.
The ZIKV ﬁeld is still developing, and critics regarding the use of the
original ZIKV strain are starting to emerge. There is currently no appro-
priate African andAsian reference strains to allow proper comparison of
results between laboratories. At this stage, we cannot disregard that the
differences observed in our study are due to intrinsic abilities or differ-
ences in infectivity of these two ZIKV strains. Whether this difference
could be explained by envelope variants and/or receptor usage or later
in the replication cycle will be the aim of future studies. One caveat of
our study is the few number of African and Asian strains used that did
not allow us to address a general conclusion regarding differences be-
tween ZIKV lineages. However, ourwork address the important concern
that circulating African ZIKV strains must be closely followed and that
ZIKV strains could have differentmolecular patterns. Studies need to in-
vestigate the neurotropismand neurovirulence ofmore circulating ZIKV
AF strains versusAS strains in order to establish their replication and cel-
lular response abilities. It is not unlikely that ZIKV outbreaks occurred
recently in Africa and remained undiscovered due to the very low ca-
pacities for detection of emerging or re-emerging pathogens in most
of the continent (Meda et al., 2016). Understanding the basic mecha-
nisms of ZIKV AF infection is therefore of crucial importance.
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